Profile data is unavailable for this security.
About the company
Advanced Medical Solutions Group plc is a United Kingdom-based developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. The Company offers a range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, bone substitutes and internal sealants, which it markets under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIXTM and SEAL-G brands. The Company also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal brand as well as under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit is comprised of multi-product portfolio of advanced wound care dressings and a portfolio of specialist medical bulk materials and multi-layer wound care products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, the Czech Republic and Israel.
- Revenue in GBP (TTM)126.21m
- Net income in GBP15.89m
- Incorporated1993
- Employees800.00
- LocationAdvanced Medical Solutions Group PLCPremier Park, 33 Road OneWINSFORD CW7 3RTUnited KingdomGBR
- Phone+44 16 0686 3500Fax+44 16 0686 3600
- Websitehttps://www.admedsol.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Tristel Plc | 39.49m | 6.04m |
Nyxoah SA | 3.72m | -36.95m |
BICO Group AB | 164.34m | -123.94m |
Lumibird SA | 174.05m | 6.09m |
Medistim ASA | 38.38m | 7.41m |
COLTENE Holding AG | 211.63m | 10.42m |
IVF Hartmann Holding AG | 129.00m | 13.21m |
Ion Beam Applications SA | 366.57m | -7.79m |
Avon Protection PLC | 195.20m | -13.13m |
CellaVision AB | 51.74m | 10.32m |
Advanced Medical Solutions Group plc | 126.21m | 15.89m |
Safilo Group SpA | 876.18m | -21.08m |
Stratec SE | 215.73m | 10.38m |
medmix AG | 424.25m | 261.56k |
Synsam AB (publ) | 431.33m | 22.72m |
Revenio Group Oyj | 82.66m | 16.25m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Octopus Investments Ltd.as of 24 Apr 2024 | 28.31m | 13.03% |
Canaccord Genuity Wealth Ltd.as of 29 Dec 2023 | 16.60m | 7.64% |
Investec Wealth & Investment Ltd.as of 29 Dec 2023 | 12.69m | 5.84% |
Charles Stanley & Co. Ltd.as of 29 Dec 2023 | 11.32m | 5.21% |
Invesco Asset Management Ltd.as of 29 Dec 2023 | 8.57m | 3.94% |
Rathbones Investment Management Ltd.as of 21 Sep 2023 | 7.17m | 3.30% |
AXA Investment Managers UK Ltd.as of 29 Dec 2023 | 6.85m | 3.15% |
Evelyn Partners Investment Management LLPas of 01 Feb 2024 | 4.02m | 1.85% |
BlackRock Fund Advisorsas of 01 Feb 2024 | 3.94m | 1.81% |
Royal London Asset Management Ltd.as of 01 Feb 2024 | 3.78m | 1.74% |